131 related articles for article (PubMed ID: 10794041)
1. Endometrial histology in long-term users of the once-a-month injectable contraceptive Cyclofem.
Bahamondes L; Maradiegue E; Diaz J; Trelles J; Escanhoela C; Petta C; Arce XE
Adv Contracept; 1999; 15(1):1-7. PubMed ID: 10794041
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of Cyclofem and depot medroxyprogesterone acetate (DMPA) effects on endometrial vasculature.
Simbar M; Tehrani FR; Hashemi Z; Zham H; Fraser IS
J Fam Plann Reprod Health Care; 2007 Oct; 33(4):271-6. PubMed ID: 17925114
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of Cyclofem in the treatment of depot medroxyprogesterone acetate induced amenorrhea.
Piya-Anant M; Koetsawang S; Patrasupapong N; Dinchuen P; d'Arcangues C; Piaggio G; Pinol A
Contraception; 1998 Jan; 57(1):23-8. PubMed ID: 9554247
[TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamic effects of once-a-month combined injectable contraceptives.
Sang GW
Contraception; 1994 Apr; 49(4):361-85. PubMed ID: 8013220
[TBL] [Abstract][Full Text] [Related]
5. Vaginal bleeding patterns in women using once-a-month injectable contraceptives.
Fraser IS
Contraception; 1994 Apr; 49(4):399-420. PubMed ID: 8013222
[TBL] [Abstract][Full Text] [Related]
6. Once-a-month injectable contraceptives: efficacy and reasons for discontinuation.
Koetsawang S
Contraception; 1994 Apr; 49(4):387-98. PubMed ID: 8013221
[TBL] [Abstract][Full Text] [Related]
7. A multicentred phase III comparative clinical trial of Mesigyna, Cyclofem and Injectable No. 1 given by intramuscular injection to Chinese women. II. The comparison of bleeding patterns.
Sang GW; Shao QX; Ge RS; Ge JL; Chen JK; Song S; Fang KJ; He ML; Luo SY; Chen SF
Contraception; 1995 Mar; 51(3):185-92. PubMed ID: 7621686
[TBL] [Abstract][Full Text] [Related]
8. Introduction of cyclofem once-a-month injectable contraceptive in Mexico.
Garza-Flores J; Moraks del Olmo A; Fuziwara JL; Figueroa JG; Alonso A; Monroy J; Perez M; Urbina-Fuentes M; Guevara SJ; Cedeno E; Barrios R; Ferman JJ; Medina LM; Velazquez E; Perez-Palacios G
Contraception; 1998 Jul; 58(1):7-12. PubMed ID: 9743890
[TBL] [Abstract][Full Text] [Related]
9. A comparative study on the return to ovulation following chronic use of once-a-month injectable contraceptives.
Bassol S; Hernandez C; Nava MP; Trujillo AM; Luz de la Cruz D
Contraception; 1995 May; 51(5):307-11. PubMed ID: 7628206
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of medroxyprogesterone acetate after single and multiple injection of Cyclofem in Chinese women.
Zhou XF; Shao QX; Han XJ; Weng LJ; Sang GW
Contraception; 1998 Jun; 57(6):405-11. PubMed ID: 9693401
[TBL] [Abstract][Full Text] [Related]
11. Comparative phase III clinical trial of two injectable contraceptive preparations, depot-medroxyprogesterone acetate and Cyclofem, in Vietnamese women.
Cuong DT; My Huong NT
Contraception; 1996 Sep; 54(3):169-79. PubMed ID: 8899259
[TBL] [Abstract][Full Text] [Related]
12. Introductory study of the once-a-month, injectable contraceptive Cyclofem in Brazil, Chile, Colombia, and Peru.
Hall P; Bahamondes L; Diaz J; Petta C
Contraception; 1997 Dec; 56(6):353-9. PubMed ID: 9494768
[TBL] [Abstract][Full Text] [Related]
13. Facts about once-a-month injectable contraceptives: memorandum from a WHO meeting.
Bull World Health Organ; 1993; 71(6):677-89. PubMed ID: 8313486
[TBL] [Abstract][Full Text] [Related]
14. A multicentred phase III comparative clinical trial of Mesigyna, Cyclofem and Injectable No. 1 given monthly by intramuscular injection to Chinese women. I. Contraceptive efficacy and sid effects.
Sang GW; Shao QX; Ge RS; Ge JL; Chen JK; Song S; Fang KJ; He ML; Luo SY; Chen SF
Contraception; 1995 Mar; 51(3):167-83. PubMed ID: 7621685
[TBL] [Abstract][Full Text] [Related]
15. Maintaining technical quality of care in the introduction of Cyclofem in a national family planning program: findings from Indonesia.
Lubis F; Fajans P; Simmons R
Contraception; 1994 May; 49(5):527-41. PubMed ID: 8045136
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of the effects of two once-a-month injectable contraceptives (Cyclofem and Mesigyna) and one oral contraceptive (Ortho-Novum 1/35) on coagulation and fibrinolysis.
United Nations Development Programme/United Nations Population Fund/World Health Organization/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-acting Systemic Agents for Fertility Regulaion
Contraception; 2003 Sep; 68(3):159-76. PubMed ID: 14561536
[TBL] [Abstract][Full Text] [Related]
17. Return of fertility after discontinuation of the once-a-month injectable contraceptive Cyclofem.
Bahamondes L; Lavín P; Ojeda G; Petta C; Diaz J; Maradiegue E; Monteiro I
Contraception; 1997 May; 55(5):307-10. PubMed ID: 9220228
[TBL] [Abstract][Full Text] [Related]
18. Acceptability of the once-a-month injectable contraceptives Cyclofem and Mesigyna in Egypt.
Hassan EO; el-Nahal N; el-Hussein M
Contraception; 1994 May; 49(5):469-88. PubMed ID: 8045133
[TBL] [Abstract][Full Text] [Related]
19. Introductory trial of the once-a-month injectable contraceptive, Cyclofem, in Indonesia.
Pandi SP; Hadjar LN; Prihyugiharto T
Adv Contracept; 1993 Mar; 9(1):33-40. PubMed ID: 8342452
[TBL] [Abstract][Full Text] [Related]
20. Self-administration with UniJect of the once-a-month injectable contraceptive Cyclofem.
Bahamondes L; Marchi NM; Nakagava HM; de Melo ML; Cristofoletti Mde L; Pellini E; Scozzafave RH; Petta C
Contraception; 1997 Nov; 56(5):301-4. PubMed ID: 9437558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
